Products of other enterprises
Technical characteristics
- Release formCapsules
Description
Therapeutic SegmentAnti-lipidemic |
Generic NameFenofibrate |
IndicationIt is indicated as adjunctive therapy to diet for the reduction of LDL-C, Total-C, Triglycerides and Apo B in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Type IIa and IIb). Fenoget is indicated as adjunctive therapy to diet for the treatment of adult patients with hypertriglyceridemia (Fredrickson types IV and V hyperlipidemia). |
BrandsFenoget |
FormCapsules |
Contact the seller
Capsules
We recommend to see